Terazol 7 Vaginal Cream 0.4% (terconazole); Terazol 3 Dual-pak - Vaginal Cream 0.8%/vaginal Ovules 80 Mg (terconazole) - Risk Of Anaphylaxis And Toxic Epidermal Necrolysis - For Health Professionals

TERAZOL Recall Summary TERAZOL 7 Vaginal Cream and TERAZOL 3 Dual-Pak products are being recalled in Canada because they carry a risk of serious allergic reactions (anaphylaxis) and a severe skin condition (toxic epidermal necrolysis). The recall affects all TERAZOL 7 0.4% cream and TERAZOL 3 products containing terconazole that were distributed across Canada.

Reason
Product safety
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2014-06-09
Status
Closed
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/90edf235-d5e8-4e51-b3be-a97850c2c987